Fundz
Back to SEC Filings
10-QHIGH RiskDETERIORATING

BIOREGENX, INC.

Filed: May 20, 2026 CIK: 0001593184
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-Q filing content

BioRegenx faces severe financial distress with $522,500 in defaulted debt including SBA loans in charge-off status, declining revenues down 17% year-over-year, and complete breakdown of internal controls. The company lacks adequate personnel and has no effective financial reporting controls, creating material weaknesses that threaten operational viability.

Red Flags Detected (7)

Multiple loan defaults totaling $522,500 including $400,000 in SBA EIDL loans

One SBA loan already in charge-off status indicating collection failure

Some defaulted notes from 2016-2018 with compounding high interest rates up to 3.5% monthly

4 more red flags detected

Key Takeaways

Company has been in default on some debt for 8+ years with compounding interest

SBA loan charge-off status indicates serious collection issues and potential federal complications

3 more takeaways

Filing Overview

Form TypeQuarterly Report (10-Q)
Filing DateMay 20, 2026
Risk LevelHIGH
TrendDETERIORATING
AI Confidence95%
Red Flags7

What This Means

High Risk Filing: This company is showing signs of financial stress or significant operational challenges.

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Quarterly Report: Interim filing with unaudited financial data for the quarter.

View Full Filing on SEC.govBrowse More Filings